SLC5A5 and cancer: In an all-comer study, a total of 9 dogs with advanced cancer were screened, enrolled, and received a single IV dose of 1010 TCID50/0.5m2 (~ 109 TCID50/kg) VSV-IFNβ-NIS (expressing either canine or human IFNβ) [69].